Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael D Hogarty

Showing results (51-60 of 102) with videos related to

Pageof 11
Sort By:
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) ReportNavin Pinto, Arlene Naranjo, Xiangming Ding, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Leukemia|March 28, 2019
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Leukemia|November 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Cancer|July 12, 2017
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupKevin Campbell, Julie M Gastier-Foster, Meegan Mann, et al.
Scientific Reports|July 15, 2021
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cellsSofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, et al.
Cancer Cell|December 18, 2014
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaScott C Bresler, Daniel A Weiser, Peter J Huwe, et al.
Cancer|August 1, 2013
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupLarry L Wang, Rie Suganuma, Naohiko Ikegaki, et al.
International Journal of Molecular Imaging|October 11, 2012
Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology GroupSteven G Dubois, Ethan Geier, Vandana Batra, et al.
Pageof 11

Showing results (51-60 of 102) with videos related to

Sort By:
Pageof 11
Pediatric and Developmental Pathology : the Official Journal of the Society for Pediatric Pathology and the Paediatric Pathology Society|September 11, 2014
Age-dependent prognostic effect by Mitosis-Karyorrhexis Index in neuroblastoma: a report from the Children's Oncology GroupRisa Teshiba, Shinya Kawano, Larry L Wang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 7, 2023
Impact of Genomic and Clinical Factors on Outcome of Children ≥18 Months of Age with Stage 3 Neuroblastoma with Unfavorable Histology and without MYCN Amplification: A Children's Oncology Group (COG) ReportNavin Pinto, Arlene Naranjo, Xiangming Ding, et al.
Oncotarget|March 25, 2016
Exome and deep sequencing of clinically aggressive neuroblastoma reveal somatic mutations that affect key pathways involved in cancer progressionVito Alessandro Lasorsa, Daniela Formicola, Piero Pignataro, et al.
Leukemia|March 28, 2019
Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Leukemia|November 24, 2019
Correction: Transient stabilization, rather than inhibition, of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphomaColleen T Harrington, Elena Sotillo, Aude Robert, et al.
Cancer|July 12, 2017
Association of MYCN copy number with clinical features, tumor biology, and outcomes in neuroblastoma: A report from the Children's Oncology GroupKevin Campbell, Julie M Gastier-Foster, Meegan Mann, et al.
Scientific Reports|July 15, 2021
MYCN-induced nucleolar stress drives an early senescence-like transcriptional program in hTERT-immortalized RPE cellsSofia Zanotti, Suzanne Vanhauwaert, Christophe Van Neste, et al.
Cancer Cell|December 18, 2014
ALK mutations confer differential oncogenic activation and sensitivity to ALK inhibition therapy in neuroblastomaScott C Bresler, Daniel A Weiser, Peter J Huwe, et al.
Cancer|August 1, 2013
Neuroblastoma of undifferentiated subtype, prognostic significance of prominent nucleolar formation, and MYC/MYCN protein expression: a report from the Children's Oncology GroupLarry L Wang, Rie Suganuma, Naohiko Ikegaki, et al.
International Journal of Molecular Imaging|October 11, 2012
Evaluation of Norepinephrine Transporter Expression and Metaiodobenzylguanidine Avidity in Neuroblastoma: A Report from the Children's Oncology GroupSteven G Dubois, Ethan Geier, Vandana Batra, et al.
Pageof 11